EUVIMEDAtrasti EUVIMED
Crossref

A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy

Jinqiao Zhang, Ting Tong, Chang Cai, Xianzhou Cai, Bicheng Sun, Kexin Wen, Xinran Qu, Qin Fan, Ziliang Dong iD

ACS Nano · 2026-06-09 · 20 (22) · 16470-16487

DOI: 10.1021/acsnano.6c06363 ↗

At a glance

Journal article in ACS Nano, published online on 2026-05-28. Written by Jinqiao Zhang and 8 co-authors. Institution: School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, P. R. China. Major MEDLINE topics: CD47 Antigen, Radioimmunotherapy, Macrophages, Receptors, Immunologic. 54 references. Funded by: Shandong First Medical University, Natural Science Foundation of Jiangsu Province, Taishan Scholar Project of Shandong Province.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Santrauka nepasiekiama.

Subjects

MeSH terms (MEDLINE)

CD47 AntigenRadioimmunotherapyMacrophagesReceptors, ImmunologicGenetic EngineeringRadiation-Sensitizing AgentsAnimalsMiceHumansCell Line, TumorFemale

Author keywords

CD47-SIRPα axisgenetic engineeringmacrophage nanodecoyphagocytosisradioimmunotherapy

Substances

CD47 AntigenReceptors, ImmunologicRadiation-Sensitizing AgentsSirpa protein, mouse

Authors and institutions

  • School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, P. R. China.
  • Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medicine Sciences, Jinan, Shandong 250117, P. R. China.
  • State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing, Jiangsu 210000, P. R. China.

ORCID profiles: Ziliang Dong

Funding

  • Shandong First Medical University
  • Natural Science Foundation of Jiangsu Province
  • Taishan Scholar Project of Shandong Province
  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China (NSFC)

Cite

APA

Zhang, J., Tong, T., Cai, C., Cai, X., Sun, B., Wen, K., Qu, X., Fan, Q., & Dong, Z. (2026). A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy. ACS Nano, 20(22), 16470-16487. https://doi.org/10.1021/acsnano.6c06363

Vancouver

Zhang J, Tong T, Cai C, Cai X, Sun B, Wen K, et al. A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy. ACS Nano. 2026;20(22):16470-16487. doi:10.1021/acsnano.6c06363

BibTeX
@article{Zhang2026,
  author = {Zhang, Jinqiao and Tong, Ting and Cai, Chang and Cai, Xianzhou and Sun, Bicheng and Wen, Kexin and Qu, Xinran and Fan, Qin and Dong, Ziliang},
  title = {A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {22},
  pages = {16470--16487},
  doi = {10.1021/acsnano.6c06363}
}
Start for free →